First in-human robotic rotor ablation for atrial fibrillation

for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528–606. 5. Duytschaever M, Mairesse G, Verbeet T, Knecht S. The right recommendations for the wrong reasons? Europace 2013;15:615–617. 6. Coseis Nielsen J, Raatikainen P, Hindricks G, Walfridsson H, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012;367: 1587–1595. 7. Morillo C, Verma A, Kuck KH, Champagne J, Nair G, Sterns L, Beresh H, Connolly SJ, Natale E. Radiofrequency ablation vs antiarrhythmic drugs as first line therapy of symptomatic atrial fibrillation: (RAAFT-2): a randomized trial. Heart Rhythm 2012;9: 1580 (abstract). 8. Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo C, Khaykin Y, Birnie D. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and aftercatheter ablation (DISCERN AF): a prospective,multicenter study. JAMA Intern Med 2013:173:149–156.